With more than 700,000 plasma aliquots from over 30,000+ patients, our biobank provides an extensive resource for research. Annual quality control checks guarantee consistent performance, making Crown Bioscience the trusted partner for high-quality, longitudinal plasma samples tailored to your research needs.
Liquid biopsies are revolutionizing cancer research. Download our white paper to stay ahead in precision medicine.
Download Now
Our meticulous protocols ensure the highest-quality plasma samples for your research. Blood samples are collected using standardized workflows, processed into plasma within 72 hours, and stored under optimal conditions at -80°C. Streck® tubes preserve cfDNA integrity, while our double-spin centrifugation method minimizes contamination. Plasma is aliquoted into 1mL vials, offering flexibility for small or large-scale studies. With robust storage protocols and advanced quality controls, Crown Bioscience guarantees the consistency and reliability of every plasma sample, providing researchers with the resources they need to succeed.
Gain valuable insights into cancer progression with longitudinal plasma samples and clinical data, offering a comprehensive view of the patient journey for biomarker discovery and treatment response analysis.
Access patient demographics, cancer type, therapy details, and tumor response for robust cohort analysis.
Leverage ctDNA analysis to identify actionable biomarkers that drive precision oncology research.
Tailor sample selection to meet your study’s specific needs, ensuring alignment with your research goals.
Connect clinical data with biomarker findings to validate discoveries and enhance cancer biology insights.
Access a vast biobank with diverse liquid biopsy samples available immediately
Samples are collected, processed, and stored with precision to maintain cfDNA and ctDNA integrity
Gain deeper insights with robust patient data supporting biomarker research
Rely on our expertise and commitment to advancing cancer research
Exploring Longitudinal Cell-free Plasma in Liquid Biopsy: Advancing Precision Oncology
